2021
DOI: 10.1016/j.biomaterials.2021.121019
|View full text |Cite
|
Sign up to set email alerts
|

Effects of purified exosome product on rotator cuff tendon-bone healing in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
63
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 38 publications
(69 citation statements)
references
References 43 publications
0
63
0
Order By: Relevance
“…Mechanical strength is an indicator of tendon healing and functional outcomes [43,44,60,61]. A recent study showed improved biomechanical properties in a repaired rotator cuff model with treatment with exosome-embedded fibrin sealant [62]. However, the effects of ADSC-EVs on repaired tendons have rarely been discussed.…”
Section: Evs Have Been Generally Accepted As a Modality Of Cell-to-cell Communication Formentioning
confidence: 99%
“…Mechanical strength is an indicator of tendon healing and functional outcomes [43,44,60,61]. A recent study showed improved biomechanical properties in a repaired rotator cuff model with treatment with exosome-embedded fibrin sealant [62]. However, the effects of ADSC-EVs on repaired tendons have rarely been discussed.…”
Section: Evs Have Been Generally Accepted As a Modality Of Cell-to-cell Communication Formentioning
confidence: 99%
“…Promisingly, this novel engineered exosomal patch can stably release particles over two weeks [ 74 ]. More organized and denser collagenous tissue and fewer inflammatory cells were also displayed at the tendon-bone interface after rotator cuff repair in the TISSEEL–PEP group [ 90 ]. Wellings et al demonstrated significantly fewer external adhesions and improved mechanical functions with the application of PEP loaded onto a collagen scaffold, indicating that the off-the-shelf PEP product favored intrinsic healing instead of extrinsic healing [ 91 ].…”
Section: Exosomes In Tendon and Repair And Regenerationmentioning
confidence: 99%
“…As we can see from this review, the development of exosomal treatments is still at a very early stage of research, and little clinical application has been accomplished. One revolutionary advance is the newly developed PEP from Mayo Clinic ( Table 1 ), which has already undergone clinical trials (human; in phase I clinical trial; ClinicalTrials.gov: NCT04664738, , accessed date: 16 March 2021) in tendon repair [ 74 , 89 , 90 ], peripheral nerve regeneration [ 184 ], vaginal tissue regeneration [ 211 ], and myocardial infarction recovery (human; in phase I clinical trial; ClinicalTrials.gov: NCT04327635, , accessed date: 2 November 2021).…”
Section: Future Directionsmentioning
confidence: 99%
“…Cell therapy involves injecting cells from other body parts or allogeneic sources into the injured site [ 175 ]. Currently, research in this field focuses on differentiated cells (tendon cells and fibroblasts) and stem cells ( Table 2 ), the main cells constituting the ECM [ 176 ]. Tendon cells and fibroblasts can produce rich growth factors to promote the healing of injured sites, and they are also the most common cells in tendon tissue [ 177 ].…”
Section: Cells That Repair Tendons and Ligamentsmentioning
confidence: 99%